![Thomas R. Ulich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas R. Ulich
Keine laufenden Positionen mehr
Profil
Thomas R.
Ulich worked as an Executive Vice President-Research & Development at ConjuChem Biotechnologies, Inc. from 2006 to 2010, Senior Vice President-Research & Development at Alnylam Pharmaceuticals, Inc. in 2003-2004, and VP-Preclinical Development & Protein Therapeutics at Amgen Canada, Inc. from 1993 to 2001.
He was also a Professor at Wayne State University and the University of California, Berkeley.
Ulich's education includes an undergraduate degree from Dartmouth College and a doctorate from the David Geffen School of Medicine.
Ehemalige bekannte Positionen von Thomas R. Ulich
| Unternehmen | Position | Ende |
|---|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Technik-/Wissenschafts-/F&E-Leiter | 30.08.2017 |
ConjuChem Biotechnologies, Inc. /Old/
 ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
| ALNYLAM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 |
ConjuChem Biotechnologies, Inc.
 ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Thomas R. Ulich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
ConjuChem Biotechnologies, Inc. /Old/
ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wayne State University (Michigan)
 Wayne State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Health Technology |
ConjuChem Biotechnologies, Inc.
ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Health Technology |
Invivo Therapeutics Holdings Corp.
 Invivo Therapeutics Holdings Corp. BiotechnologyHealth Technology Develops technologies for the treatment of spinal cord injuries | Health Technology |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
